selective amygdalohippocampectomy选择性amygdalohippocampectomy.pdfVIP

Hindawi Publishing Corporation Epilepsy Research and Treatment Volume 2012, Article ID 382095, 8 pages doi:10.1155/2012/382095 Review Article Selective Amygdalohippocampectomy David Spencer1 and Kim Burchiel2 1 Department of Neurology, Oregon Health Science University, Portland, OR 9739, USA 2 Department of Neurological Surgery, Oregon Health Science University, Portland, OR 97239, USA Correspondence should be addressed to David Spencer, spencerd@ Received 8 November 2010; Revised 22 February 2011; Accepted 25 March 2011 Academic Editor: Seyed M. Mirsattari Copyright © 2012 D. Spencer and K. Burchiel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Epilepsy surgery can be an effective epilepsy treatment for patients whose seizures do not respond to best medical therapy. For patients with temporal lobe epilepsy, selective amygdalohippocampectomy (SAH) has emerged as a viable alternative to standard anterior temporal lobectomy. This paper reviews the indications for SAH, the technical advances that have led to greater adoption of the procedure, the expectations for seizure control, and the risks of morbidity. 1. Introduction ATL offers advantages of good surgical exposure to allow complete resection of mesial structures, relatively low mor- Epilepsy is a common condition that affects nearly 1% bidity, and permits pathological examination of en bloc spec- of the world’s population. The World Health Organization imens. This procedure is still commonly em